TechCrunch
SEPTEMBER 9, 2021
Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Venture investing in elder tech.
TechCrunch
DECEMBER 20, 2021
In addition to his venture investing knowledge, Bill has decades of management operations experience. 4 strategies for building a digital health unicorn. The virtual state of corporate venture capital today. billion in venture funding across 541 deals, dwarfing the previous record of $14.6 More posts by this contributor.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
APRIL 6, 2022
Matias Serebrinsky is a partner at PsyMed Ventures, a venture fund expanding access to psychedelic medicine and mental health tech. Greg Kubin is a partner at PsyMed Ventures and co-host of Business Trip. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Greg Kubin. Contributor.
TechCrunch
NOVEMBER 3, 2021
BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.
TechCrunch
JULY 28, 2021
MedRhythms secured $25 million in Series B funding to advance its digital therapy platform aimed at measuring and improving someone’s ability to walk after they have experienced a neurologic injury or disease. A year ago, MedRhythms’ digital therapeutic product received Breakthrough Device designation from the U.S.
TechCrunch
OCTOBER 18, 2021
In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. That round was led by by GSR Ventures, with participation from existing investors Sequoia Capital, Storm Ventures, NextGen Venture Partners and BIXINK Therapeutics.
TechCrunch
FEBRUARY 10, 2022
With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness. Mental health startups are raising spirits and venture capital. million Series B, which was three times oversubscribed within two months.
Expert insights. Personalized for you.
93 
Let's personalize your content